300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Music
Art
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Pakistan
Romania
Oman
Poland
Puerto Rico
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Morocco
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Moldova
Seychelles
Botswana
Paraguay
Ireland
Canada
United Kingdom
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Malaysia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
Germany
India
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Cyprus
Qatar
Argentina
Bangladesh
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 30 Biotech Angel Investors in Singapore (August 2026)

The most active angel investors investing in Singapore Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Singapore Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Tak Wai Chung
Angel
2 Singapore Seed, Angel Food Processing, Waste Management
Paul Buchheit
Angel
2 United States, Canada, India Seed, Series A, Angel Software, Artificial Intelligence, E-Commerce $100k–$14M
Te Ling Nai
Angel
2 Singapore Seed, Angel Food Processing, Waste Management
Frederik Vandermarlie
Angel
1 Belgium, Singapore Seed Medical, Legal Tech, Health Care $2.3M–$4M
Gireesh Narsimhan
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
John Ballantyne
Angel
1 United States, Singapore Seed, Series A, Angel Health Care, Biotechnology, Therapeutics $4.5M–$30M
Wendou Niu
Angel
1 Singapore Series A Life Science, Biotechnology
Raman Singh
Angel
1 Singapore Series A Life Science, Biotechnology
Kuldeep Rajput
Angel
1 Singapore Series A Life Science, Biotechnology
Johannes Hille
Angel
1 Singapore Seed Medical, Health Care, Biotechnology
Kane Black
Angel
1 Angel
Chang Kim
Angel
1 United States Pre-Seed, Seed, Series A Gaming, Ad Network, Loyalty Programs $1.3M–$2.8M
Leo Lozner
Angel
1 Singapore, United States Angel, Series A Sports, Fitness, Genetics
Idgar Van Kippersluis
Angel
1 Singapore Seed AgTech, Agriculture, Animal Feed
Eric Urhane
Angel
1 United States, Mexico, Singapore Seed, Angel Software, Health Care, Biotechnology $1.1M–$1.9M
Jeffrey Tiong
Angel
1 Singapore Pre-Seed, Seed Health Care, Information Technology, Artificial Intelligence $738k–$4M
Siu Quek
Angel
1 Singapore, Indonesia Seed, Pre-Seed, Series A Health Care, Education, Information Technology $260k–$7.6M
Matt Cutts
Angel
1 United States, Canada, Mexico Seed, Angel, Series A SaaS, Health Care, Medical $493k–$2.8M
Feng Hu
Angel
1 United States, India, Singapore Seed, Pre-Seed, Convertible Note Communities, Mobile Apps, CRM $1.3M–$1.4M
Roy Oron
Angel
1 United States, Israel, Singapore Seed, Pre-Seed, Series A Software, Artificial Intelligence, Mobile $700k–$1.5M
Nadav Rosenberg
Angel
1 United Kingdom, France, Israel Seed, Pre-Seed, Series A Software, Biotechnology, Artificial Intelligence $850k–$21M
Benjamin Boyer
Angel
1 United States, China, Singapore Series C, Seed, Series B Software, Internet, E-Commerce $1.2M–$110M
Bud Biswas
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
Evan DiMeglio
Angel
1 United States, Canada, Singapore Seed, Pre-Seed, Series B Software, E-Commerce, Gaming $3.2M–$4M
Xiangliang Lin
Angel
1 Singapore, United Kingdom Seed Medical, Biopharma, Health Care
Y S Shashidhar
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
Alice Foo
Angel
1 Singapore Pre-Seed Recycling, Biotechnology, Waste Management
Ravindran Govindan
Angel
1 Singapore Seed Health Care, Biotechnology, Health Diagnostics
Jack Wang
Angel
1 Singapore Seed Fertility, Biotechnology, Medical Device
Ron Sim
Angel
1 Singapore Series A Beauty, Fitness, Genetics
Access all 36 angel investors in Singapore Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Tak Wai Chung
Angel · Hong Kong, Hong Kong Island, Hong Kong · 2 investments in Singapore Biotech startups

Tak Wai CHUNG joined EQT Partners in February 2009 as a Vice President.Tak Wai holds a Bachelor of Arts degree in Molecular Biology and Biochemistry and Mathematics-Economics from Wesleyan University (High Honors, Phi Beta Kappa), and a Master of Business Administration degree from the Tuck School of Business at Dartmouth.Prior to joiningEQT Partners, Tak Wai was with Lehman Brothers for over six years. While at Private Equity in Hong Kong, he focused on making direct investments into China. Before that, he was in the Investment Banking division covering primarily telecommunications, financial institutions and natural resources in both New York and Hong Kong.Tak Wai is a member of the Mid Market Partners Investment Committee and the Greater China II Internal Investment Committee.

Show more...

Investment focus

  • Industry: Food Processing, Waste Management
  • Stage:Seed, Angel
  • Geography: Singapore

Investor stats

  • Total investments: 2
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Show all investments...

Paul Buchheit
Angel · Mountain View, California, United States · 2 investments in Singapore Biotech startups

Paul Buchheit is based out of Mountain View, California and is the Co-Founder and General Partner of Standard Capital. Paul Buchheit attended Case Western Reserve University.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, E-Commerce
  • Stage:Seed, Series A, Angel
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 153
  • Round size: Seed $1.1M–$5M; Angel $100k–$1.6M; Series A $2.5M–$14M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • SiPhox Health — Painless, 5-minute biomarker testing at home. Clear insights, trend tracking, and a personalized plan built around your results.
  • BuildForever — BuildForever build products that feel personal, magical and deeply human.
  • Perplexity — Perplexity is a search engine platform that uses artificial intelligence to provide large language models and search engines. The company's platform enables the development of beneficial artificial general intelligence, as well as an open-source environment that is accessible to the public, allowing clients to develop skills and knowledge inartificial intelligence.
Show all investments...

Te Ling Nai
Angel · 2 investments in Singapore Biotech startups

Te-Ling Nai is an individual investor.

Show more...

Investment focus

  • Industry: Food Processing, Waste Management
  • Stage:Seed, Angel
  • Geography: Singapore

Investor stats

  • Total investments: 2
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Ento Industries — At ENTO INDUSTRIES, food waste is given a new lease of life. Our focus as a biotechnology company is to close the loop on food waste with the help of our army of Black Soldier Flies.
Show all investments...

Frederik Vandermarlie
Angel · 1 investments in Singapore Biotech startups

Frederik Vandermarlie

Show more...

Investment focus

  • Industry: Medical, Legal Tech, Health Care
  • Stage:Seed
  • Geography: Belgium, Singapore

Investor stats

  • Total investments: 2
  • Round size: Seed $2.3M–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
  • Henchman — Effortlessly find the clauses you’re looking for by applying our AI to your existing contracts.
Show all investments...

Gireesh Narsimhan
Angel · Pune, Maharashtra, India · 1 investments in Singapore Biotech startups

Gireesh Narsimhan

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

John Ballantyne
Angel · Fargo, North Dakota, United States · 1 investments in Singapore Biotech startups

John Ballantyne is a founder of Agathos Biologics. He co-founded Aldevron with Michael Chambers in 1998 and has been the Chief Scientific Officer since its establishment. His innovative work at Aldevron includes creation of the GMP Source product line and collaborative research with military scientists in the development of vaccine andpassive-based countermeasures to lethal and potentially weaponized viral hemorrhagic threats such as Ebola, Marburg and some hantavirus family members. He leads the research and development team at Aldevron which develops new methods and products through internal programs, collaborations, and technology licensing. John sees the advances in biotechnology providing opportunities for Agathos to enable ethical pharmaceutical development that will benefit patients, employees, and society. Ballantyne received undergraduate degrees in Pharmacy from the Central Institute of Technology and the University of Otago in New Zealand. After beginning graduate school in New Zealand he transferred to the United States in 1994 and completed his Ph.D. in Pharmaceutical Sciences at North Dakota State University.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Therapeutics
  • Stage:Seed, Series A, Angel
  • Geography: United States, Singapore

Investor stats

  • Total investments: 11
  • Round size: Seed $4.5M–$7M; Series A $12M–$30M
  • Lead/follow: 55% lead, 45% follow

Portfolio highlights

  • VerImmune — Located in Baltimore, Maryland, VerImmune is an Immuno-Oncology company developing a first-in-class cancer therapy known as Anti-tumor Immune Redirection. This strategy utilizes a proprietary tumor-specific, tumor type agnostic, virus-inspired platform termed Anti-tumor Immune Redirection Virus-inspired Particles (AIR-ViPs) that redirectspre-existing pathogenic or childhood vaccine immune memory towards tumors.
  • SmartWorx — Enterprise no-code platform. Build governed, AI-powered enterprise applications without writing a single line of code. Not bolted on. Built in.
  • GlucoTrack — GlucoTrack is a medical device manufacturing company that specializes in developing a non-invasive glucose monitoring devices. It has developed a medical device that measures glucose levels using three non-invasive technologies, ultrasound, thermal, and electromagnetic.
Show all investments...

Wendou Niu
Angel · 1 investments in Singapore Biotech startups

Co-founder & Chief Privacy Officer @ Biofourmis

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Show all investments...

Raman Singh
Angel · 1 investments in Singapore Biotech startups

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Show all investments...

Kuldeep Rajput
Angel · 1 investments in Singapore Biotech startups

Founder & CEO @ Biofourmis

Show more...

Investment focus

  • Industry: Life Science, Biotechnology
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Neuroglee Therapeutics — Providing immediate access to clinically proven, comprehensive memory and dementia care and support for care partners that improves experience, outcomes and costs.
Show all investments...

Johannes Hille
Angel · 1 investments in Singapore Biotech startups

Johannes Hille

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • X-ZELL — Early, pain-free cancer cell detection
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Kane Black
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotech startups

A seasoned technology entrepreneur, with an extensive and diverse international career in senior and executive leadership across the technology, biotechnology, medical device and healthcare investment sectors globally.Mr. Black began his career with Tokyo Stock Exchange (Jasdaq) listed semiconductor trading company Adtec Corporation K.K (nowknown as AKIBA Holdings (6840:Tokyo) becoming Director and Head of Operations for Europe, based in London U.K. In 2005 he was instrumental in the takeover of Adtec Corporation by Japanese technology company Shinden Hightex Corporation (3131:Tokyo) and remained a Director with the company, based in London.In 2012 he co – founded Nova Satra Health to leverage the latest developments in medical technologies with a view to developing, collaborating and commercialising these cutting-edge therapies across the med tech spectrum. This led, in 2014, to the establishment of Singapore based molecular diagnostic developer Nova Satra Dx Pte Ltd.In August 2019 Nova Satra Dx merged with another women’s health focused molecular diagnostics developer, INEX Innovations Exchange in a US$72 Million deal - creating INEX Innovate.In 2020 Mr. Black was invited to sit as Council Member of the National University of Singapore's, NUS Medicine International Council and in 2022 was selected as EY Singapore Entrepreneur of the Year - Biotechnology

Show more...

Investment focus

  • Stage:Angel

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Nova Satra Dx — Nova Satra Dx is a molecular diagnostics company headquartered in Singapore. The company is committed to empowering patients and physicians through the research, development and commercialisation of novel blood based diagnostic tests. These tests provide rapid and accurate detection of cancer using Asian-specific epigenetic biomarkers. Based onits clinically validated NovoTect™ technology developed by the University of Oxford, Nova Satra’s diagnostic tests can detect and identify changes in gene expression which are linked to cancer. The company is developing a pipeline of tests for breast, colon, prostate, stomach and lung cancers. For more information, please visit www.novasatra.com
Show all investments...

Chang Kim
Angel · San Francisco, California, United States · 1 investments in Singapore Biotech startups

Chang Kim is the CEO of Tapas Media.

Show more...

Investment focus

  • Industry: Gaming, Ad Network, Loyalty Programs
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $1.3M–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Luckmon — Luckmon Mobile Games Website Let's Play our games and collect gift card.
  • Noah's Farm — Noah's Farm is an AI-based flavor factor developer that leverages advanced machine learning algorithms and data-driven sensory analysis to discover, design, and optimize novel flavor compounds, enabling food and beverage companies to create unique, consistent, and consumer-preferred taste experiences more efficiently and sustainably.
  • The Data Foundation — Story is AI-native infrastructure for the intellectual property economy.
Show all investments...

Leo Lozner
Angel · 1 investments in Singapore Biotech startups

Investment focus

  • Industry: Sports, Fitness, Genetics
  • Stage:Angel, Series A
  • Geography: Singapore, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Gero — Utilizing whole-exome sequencing data for in-human AI drug discovery
  • Zenia — Thanks to Zenia, yoga beginners now have easier and more affordable access to dive into yoga at home and practice with all the information they need. We believe nothing looks as good as healthy feels.Safety first. We’ve built Zenia to be a guide that adapts to your pace, monitors the progress, and gives gentle corrections. Whether you want tostart yoga, build strength, get in shape, feel better, or be inspired, the app will help you to achieve your goals.Easy. Safe yoga practice doesn’t need to happen at an offline yoga studio. You can access the Zenia studio online from the comfort of your home and, while you’re at it, get instant feedback from your teacher.
Show all investments...

Idgar Van Kippersluis
Angel · 1 investments in Singapore Biotech startups

Distinguished Fellow @ INSEAD Distinguished Fellow @ INSEAD

Show more...

Investment focus

  • Industry: AgTech, Agriculture, Animal Feed
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • INSEACT — Biotech company producing protein from black soldier fly insects
Show all investments...

Eric Urhane
Angel · 1 investments in Singapore Biotech startups

Eric Urhane

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Angel
  • Geography: United States, Mexico, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $1.1M–$1.9M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Chirply — Chirply is a platform for crowd-sourcing & crowd-curating design. Chirply's mission is to build engagement, stickiness, and virality through crowd-sourcing design. Initially the company focused on the launch of a marketplace for crowd-sourced design for paper goods - an industry that hasn't been disrupted since the advent of theprinting press. Chirply then launched a B2B platform for crowd-sourced design for brands to help engage users and use design to make daily products inspiring.
Show all investments...

Jeffrey Tiong
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotech startups

Jeffrey Tiong is the Founder & CEO of PatSnap. Jeffrey Tiong attended the National University of Singapore. Jeffrey Tiong has received the IT Leader Award 2019 SCS and EY Entrepreneur of the year 2018 Singapore.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Artificial Intelligence
  • Stage:Pre-Seed, Seed
  • Geography: Singapore

Investor stats

  • Total investments: 4
  • Round size: Pre-Seed $738k–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Formas.AI — The Best AI Orchestrator for Architecture, Interior Design & Spatial Planning. Sketch to Image, Instant Video Narratives, 3D Rendering, Vibe Architecture.
  • Mito Health — An AI-Powered medical team dedicated to optimising your health. Focusing on in-depth diagnostics and evidence-based strategies across 5 key pillars of nutrition, sleep, exercise, supplements and mental well-being.
  • StratifiCare — At StratifiCare, we focus on the development and manufacturing of IVD (In-Vitro Diagnostics) assay solutions for personalized medicine. With more than 50 years of cumulative in-depth experience in Biomedical R&D and technology commercialization, StratifiCare strives to empower personalised medicine.
Show all investments...

Siu Quek
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotech startups

Siu Rui Quek is the Co-founder and CEO of Carousell. Siu Rui previously worked at VSee as a Collaboration Evangelist. Siu Rui Quek attended the National University of Singapore. Siu Rui Quek has received the Asia's Most Influential Award, Outstanding Young Alumni Award, and Eminent Business Alumni Award.

Show more...

Investment focus

  • Industry: Health Care, Education, Information Technology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Singapore, Indonesia

Investor stats

  • Total investments: 14
  • Round size: Seed $743k–$7.6M; Pre-Seed $260k–$1.3M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Yolk.fm — Yolk.fm is a social platform that allows users to chat rather than send text messages.
  • Evo — Social Commerce Software
  • Circular — We are making subscriptions the best way to experience tech. Circular aims to accelerate the circular economy and maximise the useful lives of each tech device to its fullest potential.
Show all investments...

Matt Cutts
Angel · San Francisco, California, United States · 1 investments in Singapore Biotech startups

Matt Cutts joined Google as a Software Engineer in January 2000. Before Google, he was working on his Ph.D. in computer graphics at the University of North Carolina at Chapel Hill. He has an M.S. from UNC-Chapel Hill, and B.S. degrees in both mathematics and computer science from the University of Kentucky.Matt wrote SafeSearch, which isGoogle's family filter. In addition to his experience at Google, Matt held a top-secret clearance while working for the Department of Defense, and he's also worked at a game engine company. He claims that Google is the most fun by far.Matt talks about webmaster-related issues on his

Show more...

Investment focus

  • Industry: SaaS, Health Care, Medical
  • Stage:Seed, Angel, Series A
  • Geography: United States, Canada, Mexico

Investor stats

  • Total investments: 11
  • Round size: Seed $493k–$2.8M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Unima — Unima is decentralizing rapid testing across industries by taking diagnostics out of the lab to the place these are needed the most to secure a timely diagnostic for everyone, anywhere.Unima is solving is the centralization of lab testing, which limits the access to a timely diagnostic for billions. Current technology for diagnostics is veryprecise and can detect almost any disease known, but the problem is these require labs with expensive equipment and specialized technicians making lab testing impossible to scale up to provide universal and timely access to diagnostics.To solve this problem Unima developed Find, a rapid testing technology platform for real time diagnostics which allows anyone to diagnose a disease directly where it is needed, without using lab equipment, with results in 15 minutes or less and at a very low cost. With Find anyone can have access to a timely diagnostic even in the most remote areas of the world.The Find platform uses shark antibodies modified with genetic engineering to detect disease biomarkers in blood, saliva, urine or water samples. These shark antibodies are used in microfluidic cards and generate a visual reactions when in contact with specific biomarkers of the disease to be tested. Then to evaluate the result of the test, a picture of the testing card is taken with the proprietary Xplora smartphone app which runs image analysis process and neural network algorithms to generate an inmediate result. Then this result,along with contextual information like geolocation, date and time, is sent to a cloud server where it can be used for real time disease tracking.
  • X-ZELL — Early, pain-free cancer cell detection
  • Meter Feeder — Easily pay for parking through MeterFeeder
Show all investments...

Feng Hu
Angel · Wellington, Wellington, New Zealand · 1 investments in Singapore Biotech startups

Feng Hu

Show more...

Investment focus

  • Industry: Communities, Mobile Apps, CRM
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, India, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $1.3M–$1.4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Credy — Credy provides instant online loan at low interest rate. Apply now for personal loan, education loan, medical loan, credit refinancing or other loans.
  • DIVE - Dating With Games — DIVE-Dating With Gaming is a trendy dating and gaming app. It offers super interesting roleplay games that break the ice and that lead to deeper and more fun experiences between matches.
  • Audetemi Inc. — Audetemi makes it easy for enterprises to enable their business on mobile, and create a superior, and engaging customer experience. Audetemi One platform allows businesses to effectively engage their customers by seamlessly integrating traditional customer engagement platforms onto their smartphones.
Show all investments...

Roy Oron
Angel · 1 investments in Singapore Biotech startups

Roy Oron is an early stage Tech/Biotech investor as well as the founder and general partner at ITI Venture Capital Partners.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Mobile
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, Israel, Singapore

Investor stats

  • Total investments: 20
  • Round size: Seed $700k–$1.5M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • 4M Analytics — 4M Analytics' unique Technology provides owners, consulting engineers, and contractors a complete, accurate, and up-to-date subsurface-infrastructure database.
  • Atlas Invest — Commercial real estate bridge loans up to $20M with same-day term sheets and funding in as few as 7 days. Institutional private credit for investors.
  • EdiTy Therapeutics — EdiTy Therapeutics is a biotechnology company that develops a gene-editing technology designed for in-vivo gene-editing of target cells. It utilizes T-cells machinery to directly deliver gene-editing agents to target cells in-vivo. Yoav Manaster established the Ness Ziona, HaMerkaz, Israel-based company in 2020.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nadav Rosenberg
Angel · London, England, United Kingdom · 1 investments in Singapore Biotech startups

Nadav leads Taboola’s expansion and operations in Europe and Australia.Prior to joining Taboola, Nadav was a member of the founding team of Groupon UK & IR, taking part in building and managing Groupon’s business in the UK.Before joining Groupon, Nadav worked as a strategy consultant with McKinsey & Company in London.Nadav isbased in London and holds an MBA from INSEAD, France.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, France, Israel

Investor stats

  • Total investments: 15
  • Round size: Seed $850k–$3.1M; Pre-Seed $2M–$2M; Series A $18M–$21M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Teora — Crude oil derived products have infiltrated every industry – synthetic colors, flavors, fragrances in food, dyes in textiles, fertilizers and packaging material that harm humans and the planet. TeOra’s mission is to replace synthetics with naturals that are manufactured in a sustainable and predictable manner. A microorganism is the best factory,optimized over billions of years of evolution and TeOra designs it to produce desired products. Using microfluidics and AI, TeOra offers 100 times faster and cheaper design of smart micro-organisms in weeks to months instead of years.
  • thymia — We use video games based on Neuropsychology alongside analyses of video and speech to make mental health assessments smart, starting with depression.Our online platform empowers clinicians so they can assess depression faster, more accurately and objectively. Our multi-modal depression recognition and tracking system allows us to find the righttreatment in weeks instead of years and we make the entire process enjoyable for the patient.
  • Lindus — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
Show all investments...

Benjamin Boyer
Angel · San Francisco, California, United States · 1 investments in Singapore Biotech startups

Ben Boyer is a Managing Director of Tenaya Capital, and he has been a member of the Tenaya investment team since 2000.Previously, Ben was a member of Lehman Brothers' Technology Investment Banking group, where he was responsible for corporate finance and strategic advisory assignments.Ben holds an M.B.A. from Stanford Graduate Schoolof Business and a B.S. in human and organizational development from Vanderbilt University.

Show more...

Investment focus

  • Industry: Software, Internet, E-Commerce
  • Stage:Series C, Seed, Series B
  • Geography: United States, China, Singapore

Investor stats

  • Total investments: 22
  • Round size: Seed $1.2M–$4.4M; Series B $12M–$50M; Series C $10M–$110M
  • Lead/follow: 36% lead, 64% follow

Portfolio highlights

  • Kangaroo — No hidden upfront costs or astronomical monthly monitoring fees. Our plans are contract-free, flexible and affordable. We even help you earn cash back on your insurance policy! Our sensors are batteries-included, peel-and-stick, app-controlled easy. Choose a free plan or professionally monitored plan for only $99/yr.
  • People.ai — Uncover the Fastest Path to Revenue
  • Triparound — All-in-one guest experience software for hotels and vacation rentals. Reduce admin time, streamline bookings, and grow ancillary revenue.
Show all investments...

Bud Biswas
Angel · San Jose, California, United States · 1 investments in Singapore Biotech startups

Bud has an impressive track record of starting networking companies and turning them into profitable businesses, and has over twenty years of industry experience in the field of high speed networking, in both technical and managerial positions. He founded Digital Technology, which was acquired by Agilent Technologies in the year 2000. He was alsoone of the founding partners of Network Software, a networking consulting company, and CCS, one of the first portable PC companies of the early 80's. Bud has an MS in Electrical Engineering and an MS in Computer Science from Ann Arbor, Michigan.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

Evan DiMeglio
Angel · New York, New York, United States · 1 investments in Singapore Biotech startups

Evan DiMeglio

Show more...

Investment focus

  • Industry: Software, E-Commerce, Gaming
  • Stage:Seed, Pre-Seed, Series B
  • Geography: United States, Canada, Singapore

Investor stats

  • Total investments: 5
  • Round size: Seed $3.2M–$4M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cyble — Cyble is a leading threat intelligence provider that obtains and processes data from the dark web and OSINT to mitigate external cybersecurity risks
  • TurtleTree — TurtleTree produces the world's first sustainable lactoferrin LF+ using precision fermentation. Animal-free, vegan-certified for food, beverages & supplements.
  • Triumph — Triumpharcade home page description
Show all investments...

Xiangliang Lin
Angel · 1 investments in Singapore Biotech startups

Xiangliang Lin

Show more...

Investment focus

  • Industry: Medical, Biopharma, Health Care
  • Stage:Seed
  • Geography: Singapore, United Kingdom

Investor stats

  • Total investments: 2
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • MFX — MFX develops microfluidic-based platforms for cell and gene therapy development and manufacturing
  • ImpacFat — ImpacFat is a food production company that develops fish meat alternatives through cell cultivation.
Show all investments...

Y S Shashidhar
Angel · 1 investments in Singapore Biotech startups

Y S Shashidhar

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

Alice Foo
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotech startups

Alice Foo is an angel investor for Alterpacks.

Show more...

Investment focus

  • Industry: Recycling, Biotechnology, Waste Management
  • Stage:Pre-Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • AlterPacks — Alterpacks - New Materials Solutions. A Singapore Management University, Institute of Innovation & Entrepreneurship, Business Innovation Generator (BIG) Incubatee.
Show all investments...

Ravindran Govindan
Angel · Singapore, Central Region, Singapore · 1 investments in Singapore Biotech startups

Ravindran Govindan - Executive Chairman and founder @ Eight Mercatus

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Cardiotrack — Cardiotrack makes preventive health screening seamless by combining at-home convenience with advanced AgenticAI-driven automation on Ethos.AI platform.
Show all investments...

Jack Wang
Angel · 1 investments in Singapore Biotech startups

Jack Wang

Show more...

Investment focus

  • Industry: Fertility, Biotechnology, Medical Device
  • Stage:Seed
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Hannah Life Technologies — We make Earth's best products and services for couples in their parenthood journey.
Show all investments...

Ron Sim
Angel · 1 investments in Singapore Biotech startups

Ron Sim

Show more...

Investment focus

  • Industry: Beauty, Fitness, Genetics
  • Stage:Series A
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Imagene Labs — Imagene Labs Pte Ltd empowers consumers to optimise their health by providing customised wellness and lifestyle solutions tailored to their unique DNA profiles. Led by medical doctors and scientists, the company provides an entire ecosystem of genomics-based solutions ranging from wellness DNA tests, personalised lifestyle recommendations, bespokeskin serums and nutritional supplements, and mobile health apps that help people live, look and feel their best.
Show all investments...

Biotech Angel investor funding in Singapore at a glance

Stats across 27 deals from 36 investors.

36
investors
in Singapore Biotech startups
27
deals
in Singapore Biotech startups
$2.6M
median round
in Singapore Biotech startups
22%
lead investors
lead at least one round
41%
Seed
most common funding stage

Access all 36 angel investors in Singapore Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Angel Investors in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 36 angel investors investing in Singapore Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists